vs
Side-by-side financial comparison of Dexcom (DXCM) and Gen Digital (GEN). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.0× Gen Digital). Dexcom runs the higher net margin — 21.2% vs 15.5%, a 5.7% gap on every dollar of revenue. On growth, Gen Digital posted the faster year-over-year revenue change (28.5% vs 21.6%). Over the past eight quarters, Gen Digital's revenue compounded faster (13.2% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Gen Digital Inc. is a multinational software company co-headquartered in both Tempe, Arizona (USA) and Prague, Czech Republic (EU). The company provides cybersecurity software, financial technology, and services. Gen is a Fortune 500 company and a member of the S&P 500 stock-market index. It is listed at both NASDAQ and Prague Stock Exchange. Its portfolio includes Norton, Avast, LifeLock, Avira, AVG, ReputationDefender, MoneyLion and CCleaner.
DXCM vs GEN — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | ||
|---|---|---|
| Revenue | $1.3B | $1.2B |
| Net Profit | $267.3M | $192.0M |
| Gross Margin | 62.9% | 78.4% |
| Operating Margin | 25.6% | 34.9% |
| Net Margin | 21.2% | 15.5% |
| Revenue YoY | 21.6% | 28.5% |
| Net Profit YoY | 153.6% | 6.1% |
| EPS (diluted) | $0.67 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.2B | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.0B | $1.0B | ||
| Q4 24 | $1.1B | $986.0M | ||
| Q3 24 | $994.2M | $974.0M | ||
| Q2 24 | $1.0B | $965.0M |
| Q1 26 | $267.3M | $192.0M | ||
| Q4 25 | $267.3M | $134.0M | ||
| Q3 25 | $283.8M | $135.0M | ||
| Q2 25 | $179.8M | — | ||
| Q1 25 | $105.4M | $142.0M | ||
| Q4 24 | $151.7M | $159.0M | ||
| Q3 24 | $134.6M | $161.0M | ||
| Q2 24 | $143.5M | $181.0M |
| Q1 26 | 62.9% | 78.4% | ||
| Q4 25 | 62.9% | 78.2% | ||
| Q3 25 | 60.5% | 78.8% | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | 80.3% | ||
| Q4 24 | 58.9% | 80.4% | ||
| Q3 24 | 59.7% | 80.1% | ||
| Q2 24 | 62.4% | 80.3% |
| Q1 26 | 25.6% | 34.9% | ||
| Q4 25 | 25.6% | 35.9% | ||
| Q3 25 | 20.1% | 35.5% | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | 41.3% | ||
| Q4 24 | 17.0% | 37.9% | ||
| Q3 24 | 15.3% | 41.3% | ||
| Q2 24 | 15.7% | 43.2% |
| Q1 26 | 21.2% | 15.5% | ||
| Q4 25 | 21.2% | 11.0% | ||
| Q3 25 | 23.5% | 10.7% | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 10.2% | 14.1% | ||
| Q4 24 | 13.6% | 16.1% | ||
| Q3 24 | 13.5% | 16.5% | ||
| Q2 24 | 14.3% | 18.8% |
| Q1 26 | $0.67 | $0.31 | ||
| Q4 25 | $0.67 | $0.21 | ||
| Q3 25 | $0.70 | $0.22 | ||
| Q2 25 | $0.45 | — | ||
| Q1 25 | $0.27 | $0.22 | ||
| Q4 24 | $0.37 | $0.26 | ||
| Q3 24 | $0.34 | $0.26 | ||
| Q2 24 | $0.35 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | $8.4B |
| Stockholders' EquityBook value | $2.7B | $2.3B |
| Total Assets | $6.3B | $15.8B |
| Debt / EquityLower = less leverage | — | 3.61× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | $1.0B | ||
| Q4 24 | $606.1M | $883.0M | ||
| Q3 24 | $621.2M | $737.0M | ||
| Q2 24 | $939.2M | $644.0M |
| Q1 26 | — | $8.4B | ||
| Q4 25 | — | $8.7B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $8.3B | ||
| Q4 24 | — | $8.5B | ||
| Q3 24 | — | $8.5B | ||
| Q2 24 | — | $8.5B |
| Q1 26 | $2.7B | $2.3B | ||
| Q4 25 | $2.7B | $2.5B | ||
| Q3 25 | $2.7B | $2.4B | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.3B | $2.3B | ||
| Q4 24 | $2.1B | $2.2B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $2.4B | $2.0B |
| Q1 26 | $6.3B | $15.8B | ||
| Q4 25 | $6.3B | $16.1B | ||
| Q3 25 | $7.5B | $16.4B | ||
| Q2 25 | $7.3B | — | ||
| Q1 25 | $6.8B | $15.5B | ||
| Q4 24 | $6.5B | $15.4B | ||
| Q3 24 | $6.4B | $15.5B | ||
| Q2 24 | $6.8B | $15.4B |
| Q1 26 | — | 3.61× | ||
| Q4 25 | — | 3.54× | ||
| Q3 25 | — | 3.75× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.64× | ||
| Q4 24 | — | 3.94× | ||
| Q3 24 | — | 4.06× | ||
| Q2 24 | — | 4.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
GEN
| Cyber Safety Platform | $819.0M | 66% |
| Trust Based Solutions | $421.0M | 34% |
| Net Interest Income On Notes Receivable | $4.0M | 0% |